Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.

NCT00294866 is registered in ClinicalTrials.gov with Fresenius Medical Care North America as lead sponsor.

NCT NCT00294866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00294866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Multi-Center Study of the Effect of Paricalcitol on Markers of Inflammation in Patients With Stage 5 Chronic Kidney Disease on Hemodialysis.
Lead sponsor
Fresenius Medical Care North America
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2006
Completion date
January 31, 2008
Enrollment
64 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

kidney failure